What is innotinib 150mg tablet used for?

This medicine contains Erlotinib 150 mg, a targeted anticancer tablet used mainly for EGFR-mutation-positive non-small cell lung cancer and advanced pancreatic cancer. It works by blocking the EGFR enzyme to slow cancer growth. It is taken once daily orally, with or without food, but grapefruit should be avoided. Common side effects include rash, diarrhoea, and fatigue. Regular monitoring of liver and lung function is essential.

Generic Name: Erlotinib (150mg)
Manufacturer: Innova Formulations Pvt Ltd
Form: Allopathy
Pregnancy Category: Consult doctor
Prescription Required: Yes

🇮🇳 innotinib 150mg tablet के बारे में (Hindi Summary)

उपयोग: यह दवा एर्लोटिनिब 150 मिलीग्राम युक्त एक लक्षित कैंसर रोधी गोली है। इसका उपयोग मुख्य रूप से उन फेफड़ों के कैंसर (नॉन-स्मॉल सेल लंग कैंसर) में किया जाता है जिनमें EGFR म्यूटेशन पाया जाता है। यह कैंसर कोशिकाओं में EGFR एंजाइम को रोककर उनकी वृद्धि को धीमा करती है। इसका उपयोग अग्नाशय के कैंसर में भी कुछ विशेष परिस्थितियों में किया जाता है। यह दवा मुँह से ली जाती है, आमतौर पर दिन में एक बार। इसे डॉक्टर की सलाह के बिना शुरू या बंद नहीं करना चाहिए।

साइड इफेक्ट्स: इस दवा के आम दुष्प्रभावों में त्वचा पर लाल चकत्ते, दस्त, जी मिचलाना, उल्टी, भूख न लगना, थकान और आँखों में जलन शामिल हैं। गंभीर दुष्प्रभावों में फेफड़ों में सूजन (इंटरस्टिशियल लंग डिजीज), लीवर की क्षति, आंत में छेद, गंभीर त्वचा प्रतिक्रियाएँ और रक्त के थक्के बनना शामिल हैं। यदि साँस लेने में तकलीफ, लगातार खांसी, बुखार, पेट में तेज दर्द, आँखों या त्वचा का पीलापन, या त्वचा पर छाले दिखें तो तुरंत डॉक्टर से संपर्क करें।

सुरक्षा सलाह: इस दवा को डॉक्टर के बताए अनुसार ही लें। गोली को पानी के साथ पूरा निगलें, चबाएँ या तोड़ें नहीं। इसे हर दिन एक ही समय पर लें, भोजन के साथ या बिना। अंगूर या अंगूर के रस के साथ इस दवा को न लें क्योंकि इससे दुष्प्रभाव बढ़ सकते हैं। धूम्रपान करने से दवा का असर कम हो सकता है, इसलिए अपने डॉक्टर को बताएं। बिना डॉक्टर की सलाह के दवा बंद न करें। नियमित रूप से लीवर और किडनी की जाँच कराते रहें। गर्भवती होने या स्तनपान कराने से पहले डॉक्टर से सलाह लें।

💊 innotinib 150mg tablet Uses & Benefits

[{"condition":"EGFR-mutation-positive non-small cell lung cancer (NSCLC)","description":"Used as first-line treatment in adults with locally advanced or metastatic NSCLC whose tumours have activating EGFR mutations.
It helps shrink tumours and delay progression.","evidence":"Well-established"},{"condition":"Advanced pancreatic cancer","description":"Used in combination with gemcitabine for the first-line treatment of locally advanced, unresectable, or metastatic pancreatic cancer.","evidence":"Established in combination therapy"},{"condition":"Maintenance therapy in NSCLC","description":"Sometimes used as maintenance treatment in patients with advanced NSCLC whose disease has not progressed after first-line platinum-based chemotherapy.","evidence":"Established in selected patients"}]

Off-label uses: [{"condition":"Head and neck squamous cell carcinoma","description":"Occasionally used off-label in recurrent or metastatic head and neck cancers, often in combination with other agents.","evidence":"Limited"},{"condition":"Glioblastoma multiforme","description":"Has been studied off-label in recurrent glioblastoma, but results have been mixed and it is not standard therapy.","evidence":"Limited"}]

Primary treatment for: EGFR-mutation-positive non-small cell lung cancer (NSCLC)

Also treats: Advanced pancreatic cancer, Maintenance therapy in NSCLC

📋 Drug Information

Generic Name(s)	Erlotinib (150mg)
Brand Name	innotinib 150mg tablet
Manufacturer	Innova Formulations Pvt Ltd
Packaging / Form	Varies by brand (Allopathy)
Therapeutic Class	ANTI NEOPLASTICS
Action Class	Tyrosine kinase inhibitors
Route of Administration	Oral
Storage	Store at room temperature between 15°C and 30°C (59°F to 86°F). Keep the tablets in their original container, tightly closed, away from moisture and direct sunlight. Do not refrigerate unless specifically instructed. Keep out of the reach of children and pets.
Shelf Life	The shelf life is typically 24 months from the date of manufacture, but refer to the expiry date printed on the pack. Do not use after the expiry date.
WHO Guideline	Erlotinib is included in WHO essential medicines list for selected indications. Guidelines recommend EGFR mutation testing before starting therapy in NSCLC. Consult your oncologist for personalised recommendations.
ICMR Guideline	ICMR guidelines recommend EGFR mutation testing in all patients with advanced NSCLC before initiating EGFR tyrosine kinase inhibitor therapy. Erlotinib is one of the recommended agents for EGFR-mutant NSCLC. Regular monitoring for adverse effects is advised.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1

Confirm EGFR mutation status before starting this medicine, as it works best in tumours with activating EGFR mutations.

2

Advise patients to take the tablet at the same time each day, with or without food, but not with grapefruit juice.

3

Monitor liver function tests regularly, especially during the first few months of treatment.

4

Educate patients about the signs of interstitial lung disease and instruct them to seek immediate care if breathlessness or cough develops.

5

Manage skin rash proactively with moisturisers and topical steroids; dose interruption may be needed for severe rash.

6

Ask patients about smoking status, as smokers may require a higher dose due to reduced drug exposure.

7

Review all concomitant medications for CYP3A4 interactions before and during treatment.

8

Advise women of childbearing potential to use effective contraception during treatment and for at least one month after the last dose.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

✅

Chronic cough and breathlessness in a lung cancer patient

This medicine is commonly prescribed for EGFR-mutant lung cancer and may help relieve these symptoms.

Likely Use

❌

Skin rash

Skin rash is a side effect of this medicine, not a reason to use it.

Not Primary

❌

Fever

This medicine is not a fever reducer. Fever may indicate infection or interstitial lung disease and should be evaluated.

Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionErlotinib is absorbed from the gastrointestinal tract after oral administration. The absolute bioavailability is approximately 60% and is not significantly affected by food. Absorption can be altered by drugs that change gastric pH, such as proton pump inhibitors.

DistributionErlotinib is widely distributed into body tissues. It is approximately 93% bound to plasma proteins, mainly albumin and alpha-1 acid glycoprotein. The volume of distribution is not well established from the available information.

Protein BindingApproximately 93% bound to plasma proteins, primarily albumin and alpha-1 acid glycoprotein.

MetabolismErlotinib is metabolised in the liver primarily by cytochrome P450 enzymes, mainly CYP3A4 and to a lesser extent CYP1A2 and CYP1A1. It undergoes extensive oxidative metabolism, and its metabolites are excreted mainly in the faeces.

Half-LifeThe elimination half-life of erlotinib is approximately 36 hours.

ExcretionErlotinib and its metabolites are excreted predominantly in the faeces (approximately 83%) and to a lesser extent in the urine (approximately 8%).

BioavailabilityThe absolute bioavailability of erlotinib is approximately 60% after oral administration.

Onset of ActionThe onset of clinical effect is not immediate. Tumour response is usually assessed after several weeks of treatment, and the full benefit may take 4 to 8 weeks or longer to become apparent.

Peak Plasma TimePeak plasma concentrations are reached approximately 4 hours after oral administration.

Duration of ActionThe pharmacological effect persists as long as the medicine is taken regularly. With a half-life of about 36 hours, steady-state concentrations are achieved in about 7 to 8 days with once-daily dosing.

How It Works

This medicine is a reversible inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. By binding to the intracellular kinase domain of EGFR, it blocks autophosphorylation of the receptor and prevents downstream activation of signalling pathways such as RAS/RAF/MAPK and PI3K/AKT. These pathways are responsible for cancer cell proliferation, survival, angiogenesis, and metastasis. In tumours that carry activating EGFR mutations, the receptor is abnormally active, and blocking it with this medicine leads to reduced tumour growth and increased cancer cell death. Because the drug targets a specific molecular abnormality, it is considered a targeted therapy rather than a conventional chemotherapy.

Mechanism Steps

1

Binding to EGFR: This medicine enters the cancer cell and binds reversibly to the ATP-binding site of the EGFR tyrosine kinase domain.

2

Blocking autophosphorylation: By occupying the ATP-binding site, the medicine prevents EGFR from phosphorylating itself and other downstream proteins.

3

Inhibition of downstream pathways: Blocking EGFR phosphorylation stops activation of RAS/RAF/MAPK and PI3K/AKT pathways that drive cancer cell growth and survival.

4

Reduced proliferation and increased apoptosis: Cancer cells that depend on EGFR signalling stop dividing and undergo programmed cell death.

5

Clinical tumour response: Over time, this leads to shrinkage of EGFR-mutant tumours and delayed progression of the cancer.

💡 How to Take innotinib 150mg tablet

Strength: Erlotinib 150 mg immediate-release tablet for oral administration.

1Take this medicine exactly as prescribed by your doctor.

2Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless your doctor tells you to.

3Take it at the same time each day, with or without food.

4Avoid taking it with grapefruit or grapefruit juice.

5If you take antacids, take them at least 2 hours before or after this medicine.

6Do not stop taking this medicine without consulting your doctor, even if you feel well.

7If you miss a dose, follow the missed dose instructions provided by your doctor.

Dosage Information

Adult Dosage	The usual adult dose of this medicine is 150 mg taken orally once daily, at least one hour before or two hours after food. For pancreatic cancer, it is often used in combination with gemcitabine. Dose adjustments may be required for severe side effects, liver impairment, or when taken with certain interacting medicines. Dose must be individualized by a qualified clinician based on indication, age, weight, renal and hepatic function, and concomitant medications.
Pediatric Dosage	Pediatric dosing is not established from available information. Consult a pediatric oncologist.
Elderly Dosage	No specific dose adjustment is recommended for elderly patients based on age alone. However, elderly patients may be more sensitive to side effects such as diarrhoea, rash, and fatigue. Close monitoring is advised, and dose adjustments should be made based on individual tolerability and organ function.
Renal Impairment	No dose adjustment is required for patients with mild to moderate renal impairment. The safety and efficacy of this medicine in patients with severe renal impairment have not been established. Use with caution and monitor closely.
Hepatic Impairment	In patients with severe hepatic impairment, the clearance of erlotinib is reduced, and the risk of toxicity is increased. Dose reduction or interruption should be considered. In patients with moderate hepatic impairment, no initial dose adjustment is recommended, but close monitoring is advised. For mild hepatic impairment, no adjustment is needed.
Maximum Daily Dose	The maximum recommended daily dose is 150 mg. Do not exceed this dose without medical supervision.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

🍽️ Food Timing Guide

With or without food

Take at the same time each day

Food does not significantly affect absorption, so you can take it with or without a meal.

Grapefruit and grapefruit juice

Avoid

Grapefruit inhibits CYP3A4 and can increase erlotinib levels, leading to more side effects.

St. John's wort

Avoid

St. John's wort induces CYP3A4 and can reduce erlotinib effectiveness.

⏰ What to Do If You Miss a Dose

📌 Less than 12 hours have passed since the missed dose

→ Take the missed dose as soon as you remember.

💡 Continue with your regular schedule the next day.

📌 More than 12 hours have passed since the missed dose

→ Skip the missed dose and take the next dose at the regular time.

💡 Do not double the dose to catch up.

⚠️ Side Effects of innotinib 150mg tablet

✅ Common Side Effects

Skin rash (acneiform) (Very common (up to 75%))

Use gentle skin care, avoid harsh soaps, and apply prescribed moisturisers. Report to your doctor if the rash becomes severe or blisters.

Diarrhoea (Very common (up to 50%))

Drink plenty of fluids, avoid spicy and fatty foods, and inform your doctor if diarrhoea persists for more than 24 hours or is severe.

Nausea and vomiting (Common (10-30%))

Take the tablet with a light meal, eat small frequent meals, and ask your doctor about anti-nausea medicines if needed.

Loss of appetite (Common (10-30%))

Eat small, frequent, nutritious meals. Consult a dietitian if weight loss occurs.

Tiredness and fatigue (Common (10-30%))

Rest when needed, maintain a balanced diet, and report persistent fatigue to your doctor.

Eye irritation or conjunctivitis (Common (5-15%))

Use lubricating eye drops if advised, avoid rubbing your eyes, and see an eye specialist if symptoms worsen.

🚨 Serious Side Effects

Interstitial lung disease (ILD) (Rare (<1%))

Seek immediate medical attention if you develop new or worsening breathlessness, cough, or fever. This medicine may need to be stopped permanently.

Severe liver injury (Uncommon (1-5%))

Report yellowing of eyes or skin, dark urine, or right upper abdominal pain immediately. Regular liver function tests are required.

Gastrointestinal perforation (Rare (<1%))

Seek emergency care for severe abdominal pain, fever, or vomiting blood.

Severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis) (Rare (<1%))

Stop the medicine and seek emergency care if you develop a blistering rash, peeling skin, or sores in the mouth or eyes.

Blood clots (venous thromboembolism) (Uncommon (1-5%))

Seek immediate medical attention for sudden leg swelling, chest pain, or difficulty breathing.

Corneal ulceration or keratitis (Rare (<1%))

See an eye specialist urgently if you experience eye pain, redness, blurred vision, or sensitivity to light.

⚠️ Rare Side Effects

Hair changes (eyelash thickening, trichomegaly)

Usually reversible after stopping treatment. Consult your doctor if bothersome.

Paronychia (nail infection)

Keep nails clean and dry, avoid cutting cuticles, and see your doctor if redness or pus develops.

Mucositis (mouth sores)

Maintain good oral hygiene, avoid spicy foods, and use prescribed mouth rinses.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug	Severity	Effect
Ketoconazole	Major
Rifampicin	Major
Omeprazole	Major
Warfarin	Major
Simvastatin	Moderate
Ibuprofen	Moderate
Theophylline	Moderate
Antacids	Minor
Ranitidine	Minor
St. John's wort	Major

🚨 Major Interactions

CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin, ritonavir)
CYP3A4 inducers (e.g., rifampicin, phenytoin, carbamazepine, St. John's wort)
Proton pump inhibitors (e.g., omeprazole, pantoprazole)
Warfarin and other anticoagulants

⚡ Moderate Interactions

Statins (e.g., simvastatin, atorvastatin)
NSAIDs (e.g., ibuprofen, naproxen)
CYP1A2 substrates (e.g., theophylline, clozapine)

🍷 Alcohol Interaction

Alcohol may worsen some side effects of this medicine, such as nausea, vomiting, and liver irritation. It is advisable to avoid or limit alcohol consumption while taking this medicine, especially if you have liver problems. Consult your doctor for personalised advice.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Known severe hypersensitivity to erlotinib or any component of the tablet","Pregnancy and breastfeeding","Severe hepatic impairment","Concurrent use with strong CYP3A4 inducers or inhibitors without dose adjustment","Patients with a history of interstitial lung disease"]

⚠️ Warnings & Precautions

["Interstitial lung disease: This medicine can cause rare but serious lung inflammation. Stop treatment and seek immediate medical attention if you develop new or worsening breathlessness, cough, or fever.","Liver toxicity: Regular monitoring of liver function is essential. Report yellowing of eyes or skin, dark urine, or abdominal pain.","Gastrointestinal perforation: Seek emergency care for severe abdominal pain, fever, or vomiting blood.","Severe skin reactions: Stop the medicine and seek urgent care if you develop a blistering rash or peeling skin.","Eye disorders: Report eye pain, redness, or blurred vision promptly.","Drug interactions: Avoid strong CYP3A4 inhibitors and inducers. Inform your doctor about all medicines you take.","Smoking: Smoking reduces the effectiveness of this medicine. Patients who smoke may need a higher dose.","Pregnancy and breastfeeding: Use effective contraception and avoid breastfeeding during treatment.","Driving and operating machinery: This medicine may cause fatigue or eye problems. Use caution until you know how it affects you."]

🤱 Lactation Safety

It is not known whether erlotinib passes into breast milk. Because of the potential for serious adverse reactions in a breastfed infant, breastfeeding should be discontinued during treatment and for at least two weeks after the last dose. Consult your doctor for guidance.

💊 Overdose Management

There is no specific antidote for an overdose of this medicine. Overdose may cause severe diarrhoea, rash, and liver toxicity. If an overdose is suspected, stop the medicine and seek immediate medical attention. Treatment is supportive and symptomatic, with close monitoring of vital signs and organ function. Contact a poison control centre or emergency department for further guidance.

⏰ Missed Dose

If you miss a dose of this medicine, take it as soon as you remember on the same day. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed dose. If you are unsure, contact your doctor or pharmacist.

Additional Safety Advice

General Safety

This medicine must only be taken exactly as prescribed by your oncologist. Swallow the tablet whole with a glass of water; do not crush, chew, or split it unless your doctor specifically instructs you to do so. Take it at the same time each day, with or without food, but avoid taking it with grapefruit or grapefruit juice because this can increase the amount of medicine in your body and raise the risk of side effects. If you smoke, tell your doctor, because smoking can reduce the effectiveness of this medicine and your dose may need to be adjusted. Do not stop taking this medicine on your own, even if you feel well, because stopping suddenly can allow the cancer to grow. Keep all scheduled blood tests and clinic appointments, as these help your doctor monitor your liver, kidneys, and overall response to treatment. Inform your doctor immediately if you become pregnant, plan to become pregnant, or are breastfeeding, because this medicine can harm an unborn baby. Use effective contraception during treatment and for at least one month after the last dose. Store the tablets at room temperature, away from moisture and direct sunlight, and keep them out of the reach of children.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients may be more susceptible to side effects such as diarrhoea, rash, fatigue, and dehydration. Close monitoring and supportive care are important. Dose adjustments should be based on individual tolerability and organ function, not age alone.

🤰 Pregnancy Planning (TTC)

This medicine can harm an unborn baby. Women of childbearing potential should use effective contraception during treatment and for at least one month after the last dose. Men with female partners of childbearing potential should also use effective contraception during treatment and for at least one month after the last dose. If you are planning pregnancy, consult your oncologist well in advance.

🏥 Post-Surgery Considerations

If you are scheduled for surgery, inform your surgeon and oncologist that you are taking this medicine. It may need to be stopped temporarily before surgery because of the risk of bleeding, poor wound healing, or interactions with anaesthetic agents. Do not stop the medicine without your doctor's advice.

🦷 Dental Procedures

Inform your dentist that you are taking this medicine before any dental procedure. It may increase the risk of bleeding or infection. Your dentist may recommend postponing elective procedures until your blood counts and overall condition are stable. Good oral hygiene is important to prevent mouth sores and infections.

💚 Lifestyle Tips for Better Results

🏃

Maintain a balanced diet rich in fruits, vegetables, and lean proteins to support your immune system.

🥗

Stay well hydrated, especially if you experience diarrhoea or vomiting.

😴

Use gentle, fragrance-free skin care products to manage rash.

💧

Avoid smoking, as it can reduce the effectiveness of this medicine.

🧘

Get adequate rest and pace your activities to manage fatigue.

🌞

Practice good hand hygiene to reduce the risk of infections.

🚭

Join a support group or talk to a counsellor to cope with the emotional aspects of cancer treatment.

🏋️ Exercise Considerations

Mild to moderate exercise is generally safe and beneficial, but consult your doctor before starting any new exercise programme. Avoid strenuous activities if you have fatigue, breathlessness, or low blood counts. If you experience chest pain, dizziness, or severe shortness of breath during exercise, stop immediately and seek medical attention.

🥗 Diet Recommendations

Eat small, frequent meals if you have nausea or loss of appetite.

Include protein-rich foods such as eggs, fish, poultry, and legumes.

Avoid spicy, greasy, or highly processed foods if you have diarrhoea.

Drink plenty of fluids to prevent dehydration.

Avoid grapefruit and grapefruit juice.

Limit alcohol consumption.

💼 Impact on Daily Work & Life

This medicine may cause fatigue, eye irritation, and skin rash, which can affect your ability to work or drive. Use caution when driving or operating machinery until you know how the medicine affects you. Discuss work adjustments with your employer if needed. Most patients can continue their daily activities with some modifications.

🛑 When to Stop This Medicine

Do not stop taking this medicine without consulting your oncologist. Your doctor may decide to stop treatment if the cancer progresses, if you develop severe side effects, or if you complete the planned course. If you experience any red-flag symptoms, seek immediate medical attention; your doctor will advise whether to continue or stop the medicine.

📅 Long-Term Use Effects

Long-term use of this medicine may lead to persistent skin changes, chronic diarrhoea, and rare but serious organ toxicities such as liver injury and interstitial lung disease. Regular monitoring of liver function, kidney function, and lung symptoms is essential. Some patients may develop resistance to the medicine over time, requiring a change in treatment. Long-term survivors should continue regular follow-up with their oncologist.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Other EGFR tyrosine kinase inhibitors

Gefitinib, afatinib, or osimertinib may be alternatives depending on the specific EGFR mutation and prior treatments.

Evidence: Well-established

Chemotherapy

Platinum-based chemotherapy may be used if targeted therapy is not suitable or stops working.

Evidence: Well-established

Immunotherapy

Immune checkpoint inhibitors may be an option in selected patients, but are generally less effective in EGFR-mutant tumours.

Evidence: Limited for EGFR-mutant NSCLC

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

Live vaccines should be avoided while taking this medicine because of the potential risk of infection. Inactivated vaccines are generally safe, but consult your oncologist before receiving any vaccine. Timing of vaccination should be discussed with your healthcare team.

📦 Storage Guide

✅ DO

Store at room temperature between 15°C and 30°C.

❌ DON'T

Do not refrigerate unless specifically instructed.

✅ DO

Keep the tablets in their original container, tightly closed.

❌ DON'T

Do not transfer to unmarked containers.

✅ DO

Keep away from direct sunlight and moisture.

❌ DON'T

Do not store in the bathroom cabinet.

✅ DO

Keep out of the reach of children and pets.

❌ DON'T

Do not use after the expiry date.

✈️ Traveling with This Medicine

When travelling, carry this medicine in its original packaging with the prescription label clearly visible. Bring a copy of your prescription and a doctor's letter explaining that you are carrying a controlled anticancer medicine. Keep the tablets in your hand luggage to avoid loss or temperature extremes. Store at room temperature and avoid direct sunlight. If crossing time zones, continue taking your dose at the same interval as prescribed; consult your doctor for specific timing advice. Check customs regulations for carrying prescription medicines in your destination country.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 58-year-old woman with EGFR-mutant lung cancer

She was started on this medicine after her oncologist confirmed an EGFR mutation. Within six weeks, her cough and breathlessness improved, and a follow-up scan showed shrinkage of the lung tumour. She developed a mild acne-like rash on her face and chest, which was managed with moisturisers and a short course of topical steroids. She learned to take the tablet at the same time every morning and avoided grapefruit juice.

💡 Lesson: Regular follow-up and proactive management of skin rash can help patients stay on treatment and achieve good tumour response.

👤 A 65-year-old man with advanced pancreatic cancer

He received this medicine in combination with gemcitabine. He experienced moderate diarrhoea and fatigue during the first month, which required a brief dose interruption. With dietary changes and anti-diarrhoeal medicines, he was able to resume treatment at a reduced dose. His oncologist monitored his liver function closely, and his disease remained stable for several months.

💡 Lesson: Dose adjustments and supportive care are important to balance efficacy and tolerability, especially in combination regimens.

💬 Questions Patients Often Ask

Q: How long does it take to work?

A: This medicine starts working at the cellular level within hours, but noticeable tumour shrinkage or symptom improvement usually takes several weeks. Your doctor will assess response with scans after about 6 to 8 weeks.

Q: Can I take this medicine with food?

A: Yes, you can take it with or without food. However, avoid grapefruit and grapefruit juice, as they can increase the levels of this medicine and cause more side effects.

Q: What should I do if I miss a dose?

A: If you remember within 12 hours of the missed dose, take it as soon as possible. If more than 12 hours have passed, skip the missed dose and continue with your regular schedule. Do not double the dose.

Q: Can I stop taking this medicine if I feel better?

A: No. Stopping this medicine without your doctor's advice can allow the cancer to grow. Always consult your oncologist before making any changes.

Q: Is this medicine safe during pregnancy?

A: No. This medicine can harm an unborn baby. Women of childbearing potential should use effective contraception during treatment and for at least one month after the last dose. Inform your doctor immediately if you become pregnant.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

Can I take this medicine long-term?
Will it affect my liver function?
Can I drive after taking this medicine?
Does it interact with my blood pressure medicine?
What if I miss a dose?
Can I drink alcohol while taking this?
Is it safe to take with other cancer medicines?
How long will I need to take this medicine?

🔄 Substitutes for innotinib 150mg tablet

View All

Alternative brands with exact same active ingredient:

Medical Note: Always consult your doctor before switching medications.

🛑 Myths vs. Facts

Myth: Erlotinib is a traditional chemotherapy that kills all fast-growing cells.
Fact: Erlotinib is a targeted therapy that specifically blocks EGFR signalling in cancer cells. It has a different side effect profile compared to conventional chemotherapy.
Myth: Once you start erlotinib, you can stop it whenever you feel better.
Fact: Stopping erlotinib without medical advice can allow the cancer to grow. Always consult your oncologist before making any changes.
Myth: Erlotinib can be taken with grapefruit juice for better absorption.
Fact: Grapefruit juice can increase erlotinib levels and cause more side effects. It should be avoided.
Myth: Erlotinib is safe during pregnancy.
Fact: Erlotinib can harm an unborn baby and is contraindicated during pregnancy. Effective contraception is essential.

🔄 Alternative Options

Generic Alternatives

Erlotinib 150 mg tablet (generic)

Brand Alternatives

Tarceva
Erlocip

📊 Comparison with Similar Medicines

[{"medicine":"Erlotinib","class":"First-generation EGFR TKI","route":"Oral","common_uses":"EGFR-mutant NSCLC, pancreatic cancer","half_life":"36 hours"},{"medicine":"Gefitinib","class":"First-generation EGFR TKI","route":"Oral","common_uses":"EGFR-mutant NSCLC","half_life":"48 hours"},{"medicine":"Osimertinib","class":"Third-generation EGFR TKI","route":"Oral","common_uses":"EGFR-mutant NSCLC, T790M mutation","half_life":"48 hours"}]

Arlcyn 150 Tablet (Erlotinib 150 mg): Complete Medicine Guide

When to Call Your Doctor IMMEDIATELY

What is innotinib 150mg tablet used for?

🇮🇳 innotinib 150mg tablet के बारे में (Hindi Summary)

💊 innotinib 150mg tablet Uses & Benefits

📋 Drug Information

👨‍⚕️ Doctor's Practical Tips

🔍 Is This Medicine Right for Your Symptom?

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

How It Works

Mechanism Steps

💡 How to Take innotinib 150mg tablet

Dosage Information

Dosage Timeline

🍽️ Food Timing Guide

⏰ What to Do If You Miss a Dose

⚠️ Side Effects of innotinib 150mg tablet

✅ Common Side Effects

🚨 Serious Side Effects

⚠️ Rare Side Effects

🔬 Drug Interactions

🚨 Major Interactions

⚡ Moderate Interactions

🍷 Alcohol Interaction

🔎 Check Your Other Medicines

🛡️ Safety & Warnings

🚫 Contraindications

⚠️ Warnings & Precautions

🤱 Lactation Safety

💊 Overdose Management

⏰ Missed Dose

Additional Safety Advice

👴 Special Considerations for Elderly

💡 For Patients Above 65

🤰 Pregnancy Planning (TTC)

🏥 Post-Surgery Considerations

🦷 Dental Procedures

💚 Lifestyle Tips for Better Results

🏋️ Exercise Considerations

🥗 Diet Recommendations

💼 Impact on Daily Work & Life

🛑 When to Stop This Medicine

📅 Long-Term Use Effects

🌿 Non-Medicine Approaches

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

📦 Storage Guide

✅ DO

❌ DON'T

✅ DO

❌ DON'T

✅ DO

❌ DON'T

✅ DO

❌ DON'T

✈️ Traveling with This Medicine

💰 Cost Analysis & Savings

👥 Real Patient Stories

💬 Questions Patients Often Ask

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

🔄 Substitutes for innotinib 150mg tablet

🛑 Myths vs. Facts

🔄 Alternative Options

Generic Alternatives

Brand Alternatives

📊 Comparison with Similar Medicines

😊 Was this information helpful?

Browse Medicines A-Z

✍️ Write a Review

❓ Ask a Question

⚠️ Report an Issue